![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Acessa Health Cleared for Uterine Fibroid Ablation Device
Acessa Health Cleared for Uterine Fibroid Ablation Device
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
October 3, 2018
The FDA granted 510(k) clearance to Acessa Health’s ProVu System, a device used to treat women with symptomatic uterine fibroids who don’t want to undergo a hysterectomy.
The system combines radiofrequency ablation, guidance mapping and ultrasound visualization to target and ablate the fibroid. The ablated fibroid is then absorbed harmlessly by the body over time.
The minimally-invasive Acessa Procedure has been clinically proven through long-term data to be a safe alternative to hysterectomy.
Upcoming Events
-
21Oct